BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2021 11:20:59 AM | Browse: 778 | Download: 2444
 |
Received |
|
2021-01-15 17:45 |
|
Peer-Review Started |
|
2021-01-15 17:47 |
|
First Decision by Editorial Office Director |
|
2021-01-31 02:39 |
|
Return for Revision |
|
2021-01-31 02:39 |
|
Revised |
|
2021-02-12 18:23 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-06-07 12:31 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-06-07 13:22 |
|
Articles in Press |
|
2021-06-07 13:22 |
|
Edit the Manuscript by Language Editor |
|
2021-07-12 03:11 |
|
Typeset the Manuscript |
|
2021-07-22 03:07 |
|
Publish the Manuscript Online |
|
2021-07-26 11:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Gastrointestinal and hepatic diseases during COVID-19 pandemic: Manifestations, mechanism and management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dina Zakaria Mohamed, Mai El-Sayed Ghoneim, Sally El-Sayed Abu-Risha, Ramy Ahmed Abdelsalam and Mohamed Abdelhalem Farag |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dina Zakaria Mohamed, MSc, Assistant Lecturer, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, El-Geish St., Tanta, El-Gharbia Governorate, Arab Republic of Egypt, Tanta 31511, Egypt. m_halem1986@yahoo.com |
| Key Words |
COVID-19; Angiotensin-converting enzyme 2; Gastrointestinal; Inflammatory bowel disease; Liver; Management |
| Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic has affected millions worldwide, with high lethality. In addition to typical respiratory symptoms of COVID-19, gastrointestinal symptoms and hepatic harm have been frequently shown during COVID-19. The main purpose of this article is to focus on the manifestations, mechanisms, and management of the gastrointestinal tract and liver that occurred during COVID-19 course. Therefore, physicians must not undervalue the digestive symptoms during COVID-19 infection and rapidly adjust the treatment options for COVID-19 patients during gastrointestinal symptoms and liver enzyme abnormalities. |
| Publish Date |
2021-07-26 11:20 |
| Citation |
Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i28/4504.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i28.4504 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
